Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius L Katzmann

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 7, 2026
Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure-a claims data analysisLisa-Marie Müller, Jonas Krampe, Julius L Katzmann, et al.
Medicine|October 22, 2021
Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case reportAdrienn Tünnemann-Tarr, Hubert Scharnagl, Julius L Katzmann, et al.
Journal of the American College of Cardiology|August 1, 2020
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art ReviewJulius L Katzmann, Chris J Packard, M John Chapman, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 28, 2025
Treatment pathways of lipid-lowering therapies in Germany 2016-2022Julius L Katzmann, Claudia Grellmann, Beate Leppert, et al.
Lipids in Health and Disease|June 1, 2020
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational studyJulius L Katzmann, Christian M Werner, Tatjana Stojakovic, et al.
Frontiers in Cardiovascular Medicine|June 30, 2022
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021Julius L Katzmann, Marita Kieble, Salka Enners, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2020
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-CJulius L Katzmann, Francesc Sorio-Vilela, Eugen Dornstauder, et al.
Atherosclerosis|August 17, 2021
Cutaneous manifestations in familial hypercholesterolaemiaJulius L Katzmann, Maximilian Lehmann, Adrienn Tünnemann-Tarr, et al.
Plos One|June 11, 2021
General health of patients with diabetic macular edema-The LIPSIA studyCatharina Busch, Julius L Katzmann, Claudia Jochmann, et al.
Clinical Pharmacology and Therapeutics|January 6, 2021
Genetic Variation in Sodium-glucose Cotransporter 2 and Heart FailureJulius L Katzmann, Amy M Mason, Winfried März, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 7, 2026
Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure-a claims data analysisLisa-Marie Müller, Jonas Krampe, Julius L Katzmann, et al.
Medicine|October 22, 2021
Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case reportAdrienn Tünnemann-Tarr, Hubert Scharnagl, Julius L Katzmann, et al.
Journal of the American College of Cardiology|August 1, 2020
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art ReviewJulius L Katzmann, Chris J Packard, M John Chapman, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 28, 2025
Treatment pathways of lipid-lowering therapies in Germany 2016-2022Julius L Katzmann, Claudia Grellmann, Beate Leppert, et al.
Lipids in Health and Disease|June 1, 2020
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational studyJulius L Katzmann, Christian M Werner, Tatjana Stojakovic, et al.
Frontiers in Cardiovascular Medicine|June 30, 2022
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021Julius L Katzmann, Marita Kieble, Salka Enners, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2020
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-CJulius L Katzmann, Francesc Sorio-Vilela, Eugen Dornstauder, et al.
Atherosclerosis|August 17, 2021
Cutaneous manifestations in familial hypercholesterolaemiaJulius L Katzmann, Maximilian Lehmann, Adrienn Tünnemann-Tarr, et al.
Plos One|June 11, 2021
General health of patients with diabetic macular edema-The LIPSIA studyCatharina Busch, Julius L Katzmann, Claudia Jochmann, et al.
Clinical Pharmacology and Therapeutics|January 6, 2021
Genetic Variation in Sodium-glucose Cotransporter 2 and Heart FailureJulius L Katzmann, Amy M Mason, Winfried März, et al.
Pageof 3